Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of ZL-82 tablets in moderate-to-severe atopic dermatitis
CTR20251409Phase 2Active
- Sponsor
- Zeling Biopharma
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZL-82 in atopic dermatitis (AD), sponsored by Zeling Biopharma. Started Feb 2026; status: active.
02
Drugs
ZL-82
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20251409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251409.